What are YOU Wearing Today: The Present & Future of Wearable Health Devices
Today, one in five Americans owns some type of wearable technology, while experts estimate that the annual smart-wearable health care market volume will grow from $2 billion in 2014 to $41 billion in 2020 (a compound annual growth rate of 65 percent!). Discover how this new technology and the incredible amounts of data it will generate promise to transform the health care continuum.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.